BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

Surein Arulananda, Megan O’Brien, Marco Evangelista, Tiffany J. Harris, Nikita S. Steinohrt, Laura J. Jenkins, Marzena Walkiewicz, Robert J.J. O’Donoghue, Ashleigh R. Poh, Bibhusal Thapa, David S. Williams, Trishe Leong, John M. Mariadason, Xia Li, Jonathan Cebon, Erinna F. Lee, Thomas John, W. Douglas Fairlie

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'BCL-XL is an actionable target for treatment of malignant pleural mesothelioma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science